Immunological aspects of epilepsy

Pharmacological Reports

Volumn 62, Issue 4, 2010, Pages 592-607

  Zarczuk, Radosław ^a   Łukasik, Dariusz ^a   Jedrych, Marian ^a   Borowicz, Kinga K ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Epilepsy; Immunology; Rasmussen encephalitis; Systemic lupus erythematosus

Indexed keywords

ANTINUCLEAR ANTIBODY; CARBAMAZEPINE; CORTICOSTEROID; CORTICOTROPIN; GANGLIOSIDE GM1; GANGLIOSIDE GM1 ANTIBODY; GLUTAMATE DECARBOXYLASE ANTIBODY; GLUTAMATE RECEPTOR 3; IMMUNOGLOBULIN; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; PHENOBARBITAL; PHENYTOIN; RECEPTOR ANTIBODY; STEROID; TUMOR NECROSIS FACTOR ALPHA; VALPROIC ACID;

ANTIBODY DETECTION; ANTIBODY TITER; ANTIPHOSPHOLIPID SYNDROME; CAUSAL ATTRIBUTION; CELLULAR IMMUNITY; CHANNELOPATHY; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG MECHANISM; DRUG MEGADOSE; DRUG PENETRATION; DRUG WITHDRAWAL; EPILEPSY; HASHIMOTO ENCEPHALOPATHY; HLA SYSTEM; HUMAN; IMMUNOPATHOLOGY; LANDAU KLEFFNER SYNDROME; LENNOX GASTAUT SYNDROME; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; PLASMAPHERESIS; PROTEIN FUNCTION; RASMUSSEN SYNDROME; REVIEW; SEIZURE; STIFF MAN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; WEST SYNDROME;

EID: 77958068481     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(10)70317-0     Document Type: Review

References (116)

1. Aarli JA: Epilepsy and the immune system. Arch Neurol, 2000, 57, 1689-1692.
2. Aarli JA: Role of cytokines in neurological disorders. Curr Med Chem, 2003, 10, 1931-1937.
3. Albertson TE, Walby WF: The effect of exogenous GM1 ganglioside on kindled-amygdaloid seizures. Neuropharmacology, 1987, 26, 261-264.
4. Andermann F, Farrell K: Early onset Rasmussen's syndrome: a malignant often bilateral form of the disorder. Epilepsy Res, 2006, 70, Suppl 1, S259-262.
5. Andrews PI, Dichter MA, Berkovic SF, Newton MR, McNamara JO: Plasmapheresis in Rasmussen's encephalitis. Neurology, 1996, 46, 242-246.
6. Antozzi C, Granata T, Aurisano N, Zardini G, Confalonieri P, Airaghi G, Mantegazza R, Spreafico R: Longterm selective IgG immune-adsorption improves Rasmussen's encephalitis. Neurology, 1998, 51, 302-305.
7. Appenzeller S, Cendes F, Costallat LT: Epileptic seizures in systemic lupus erythematosus. Neurology, 2004, 63, 1808-1812.
8. Balosso S, Ravizza T, Perego C, Peschon J, Campbell IL, De Simoni MG, Vezzani A: Tumor necrosis factor-α inhibits seizures in mice via p75 receptors. Ann Neurol, 2005, 57, 804-812.
9. Baran H, Kepplinger B, Draxler M, Skofitsch G: Choline acetyltrasferase, glutamic acid decarboxylase and somatostatin in the kainic acid model of chronic temporal lobe epilepsy. Neurosignals, 2004, 13, 290-297.
10. Bartolomei F, Boucraut J, Barrie M, Kok J, Dravet C, Viallat D, Bernard D, Gastaut JL: Cryptogenic partial epilepsies with anti-GM1 antibodies: a new form of immune mediated epilepsy? Epilepsia, 1996, 37, 922-926.
11. Basaran N, Hincal F, Kansu E, Cider A: Humoral and cellular immune parameters in untreated and phenytoinor carbamazepine-treated epileptic patients. Int J Immunopharmacol, 1994, 16, 1071-1077.
12. Basta-Kaim A, Budziszewska B, Lasoñ W: Effect of antiepileptic drugs on immunological system (Polish). Przegl Lek, 2008, 65, 799-802.
13. Bien CG, Granata T, Antozzi C, Cross JH, Dulac O, Kurthen M, Lassmann H et al.: Pathogenesis, diagnosis and treatment of Rasmussen encephalitis: a European consensus statement. Brain, 2005, 128, 454-471.
14. Billiau AD, Witters P, Ceulemans B, Kasran A, Wouters C, Lagae L: Intravenous immunoglobulins in refractory childhood-onset epilepsy: effects on seizure frequency, EEG activity and cerebrospinal fluid cytokine profile. Epilepsia, 2007, 48, 1739-1749.
15. Billiau AD, Wouters CH, Lagae LG: Epilepsy and the immune system: is there a link? Eur J Paediatr Neurol, 2005, 9, 29-42.
16. Bleck TP, Smith MC: Possible induction of systemic lupus erythematosus by valproate. Epilepsia, 1990, 31, 343-345.
17. Bostantjopoulou S, Hatzizisi O, Argyropoulou O, Andreadis S, Deligiannis K, Kantaropoulou M, Kazis A et al.: Immunological parameters in patients with epilepsy. Funct Neurol, 1994, 9, 11-15.
18. Brashear HR, Phillips LH: Autoantibodies to GABAergic neurons and response to plasmapheresis in stiff-man syndrome. Neurology, 1991, 41, 88-92.
19. Buckley C, Oger J, Clover L, Tuzun E, Carpenter K, Jackson M, Vincent A: Potassium channel antibodies in two patients with reversible limbic encephalopathies. Ann Neurol, 2005, 50, 73-78.
20. Caldiroli E, De Ponti F, Cosentino M, Marino F, Fietta AM, Taddei M, Tartara A et al.: Carbamazepine affects neutrophil function through an action on peripheral benzodiazepine receptors. Immunopharmacol Immunotoxicol, 1997, 19, 367-382.
21. Caldiroli E, Marino F, Cosentino M, De Ponti F, Fietta AM, Mazzone A, Zibetti A et al.: Peripheral benzodiazepine receptor expression on leukocytes and neutrophil function during anticonvulsant monotherapy. Pharmacology, 1998, 57, 215-221.
22. Chapman J, Cohen-Armon M, Shoenfeld Y, Korczyn AD: Antiphospholipid antibodies permeabilize and depolarize brain synaptoneurosomes. Lupus, 1999, 8, 127-133.
23. Chaudhuri A, Behan PO: The clinical spectrum, diagnosis, pathogenesis and treatment of Hashimoto's encephalopathy (recurrent acute disseminated encephalomyelitis). Curr Med Chem, 2003, 10, 1945-1953.
24. Choi J, Koh S: Role of brain inflammation in epileptogenesis. Yonsei Med J, 2008, 49, 1-18.
25. Cimaz R, Romeo A: Prevalence of anti-cardiolipin, anti-β2 glycoprotein I, and anti-prothrombin antibodies in young patients with epilepsy. Epilepsia, 2002, 43, 52-59.
26. Conolly AM, Chez MG, Pestronk A, Arnold ST, Mehta S, Deuel RK: Serum autoantibodies to brain in Landau-Kleffner variant, autism, and other neurologic disorders. J Pediatr, 1999, 134, 607-613.
27. Dabbagh O, Gascon G, Crowell J, Bamoggadam F: Intraventricular interferon-α stops seizures in Rasmussen's encephalitis: a case report. Epilepsia, 1997, 38, 1045-1049.
28. De Giorgio CM, Rabinowicz AL, Olivas RD: Carbamazepine-induced antinuclear antibodies and systemic lupus erythematosus-like syndrome. Epilepsia, 1991, 32, 128-129.
29. Echenne B, Dulac O, Parayre-Chanez MJ, Chiron C, Taillebois L, Cognot C, Andary M et al.: Treatment of infantile spasms with intravenous gamma-globulins. Brain Dev, 1991, 5, 313-319.
30. Eeg-Olofson O, Osterland CK, Guttmann RD, Andermann F, Prachal JF, Andermann E, Janjua NA: Immunological studies in focal epilepsy. Acta Neurol Scand, 1988, 78, 358-368.
31. Elenkov IJ, Iezzoni DG, Daly A, Harris AG, Chrousos GP: Cytokine dysregulation, inflammation and wellbeing. Neuroimmunoimmodulation, 2005, 12, 255-269.
32. Eevsev VA, Vetrile LA, Karpova MN: Neuroimmunopathologic aspects of epilepsy. Vestn Ross Akad Med Nauk, 2004, 8, 43-46.
33. Fayad MN, Choueiri R, Mikati M: Landau-Kleffner syndrome: consistent response to repeated intravenous γ-globulin doses: a case report. Epilepsia, 1997, 38, 489-494.
34. Feichtinger M, Wiendl H, Körner E, Holl A, Gruber L, Fazekas F, Schrottner O et al.: No effect of immunomodulatory therapy in focal epilepsy with positive glutamate receptor type 3-antibodies. Seizure, 2006, 15, 350-354.
35. Fighera MR, Bonini JS, de Oliveira TG: GM1 ganglioside attenuates convulsions and thiobarbituric acid reactive substances production induced by the intrastriatal injection of methylmalonic acid. Int J Biochem Cell Biol, 2003, 35, 465-473.
36. +-ATPase activity inhibition and oxidative stress induced by glutaric acid and pentylenetetrazole. Neurobiol Dis, 2006, 22, 611-623.
37. French JA: Refractory epilepsy: clinical overview. Epilepsia, 2007, 48, Suppl 1, 3-7.
38. Gaeta F, Alonzi C, Valluzzi RL, Viola M, Elia M, Romano A: Hypersensitivity to lamotrigine and nonaromatic anticonvulsant drugs: a review. Curr Pharm Des, 2008, 14, 2874-2882.
39. Gahring LC, White HS, Skradski SL, Carlson NG, Rogers SW: Interleukin-1α in the brain is induced by audiogenic seizure. Neurobiol Dis, 1997, 3, 263-269.
40. Ganor Y, Goldberg-Stern H, Amrom D, Lerman-Sagie T, Teichberg VI, Pelled D, Futerman AH et al.: Autoimmune epilepsy: some epilepsy patients harbor autoantibodies to glutamate receptors and dsDNA on both sides of the blood-brain barrier, which may kill neurons and decrease in brain fluids after hemispherotomy. Clin Dev Immunol, 2004, 11, 241-252.
41. Garzon P, Gonzalez-Coruejo S, Hernández-Hernández G, Aguirre-Portillo L, Almodovar-Cuevas C, Navarro-Ruiz A: Effects of antiepileptic drugs on concentration of serum proteins and immunoglobulins of epileptic patients. Gen Pharmacol, 1986, 17, 49-55.
42. Gibbs JW, Hussain AM: Epilepsy associated with lupus anticoagulant. Seizure, 2002, 11, 207-209.
43. Gołab J, Jakóbisiak M, Zagozdzon R: Cytokines (Polish). In: Immunology. Ed. Goła{ogonek}b J, Jakóbisiak M, Lasek W, PWN, Warszawa, 2004, 198-247.
44. Gross-Tsur V, Shalev RS, Kazir E, Engelhard D, Amir N: Intravenous high-dose gammaglobulins for intractable childhood epilepsy. Acta Neurol Scand, 1993, 3, 204-209.
45. Guevara-Campos J, Gonzalez-de Guevara L: Landau-Kleffner syndrome: an analysis of 10 cases in Venezuela. Rev Neurol, 2007, 44, 652-656.
46. Gupta R, Appleton R: Corticosteroids in the management of the pediatric epilepsies. Arch Dis Child, 2005, 90, 379-384.
47. Hamano S, Yamashita S, Tanaka M, Yoshinari S, Minamitani M, Eto Y: Therapeutic efficacy and adverse effects of adrenocorticotrophic hormone therapy in West syndrome: differences in dosage of adrenocorticotrophic hormone, onset of age, and cause. J Pediatr, 2006, 148, 485-488.
48. Hanisch UK, Quirion R: Interleukin-2 as a neuroregulatory cytokine. Brain Res Rev, 1995, 21, 246-284.
49. Haraldsson A, van Engelen BG, Renier WO, Bakkeren JA, Weemaes CM: Light chain ratios and concentrations of serum immunoglobulins in children with epilepsy. Epilepsy Res, 1992, 3, 255-260.
50. Hart YM, Cortez M, Andermann F, Hwang P, Fish DR, Dulac O, Silver K et al.: Medical treatment of Rasmussen's syndrome (chronic encephalitis and epilepsy): effect of high-dose steroids or immunoglobulins in 19 patients. Neurology, 1994, 44, 1030-1036.
51. Haspolat Ş, Baysal Y, Duman Ö, Cothkun M, Tosun Ö, Yegin O: Interleukin-1α, interleukin-1β, and interleukin-1Ra polymorphisms in febrile seizures. J Child Neurol, 2005, 20, 565-568.
52. Hattori A, Ando N, Hamaguchi K, Hussein MH, Fujimoto S, Ishikawa T, Togari H: Short-duration ACTH therapy for cryptogenic West syndrome with better outcome. Pediatr Neurol, 2006, 35, 415-418.
53. He XP, Patel H, Whitney KD, Janumpalli S, Tenner A, McNamara JO: Glutamate receptor GluR3 antibodies and death of cortical cells. Neuron, 1998, 20, 153-163.
54. Hrachovy RA, Frost JD Jr, Pollack MS, Glaze DG: Serologic HLA typing in infantile spasms. Epilepsia, 1988, 29, 817-819.
55. Illum N, Taudorf K, Heilmann C, Smith T, Wulff K, Mansa B, Platz P: Intravenous immunoglobulin: a single-blind trial in children with Lennox-Gastaut syndrome. Neuropediatrics, 1990, 21, 87-90.
56. Jaseja H: A plausible explanation for superiority of adreno-cortico-trophic hormone (ACTH) over oral corticosteroids in management of infantile spasms (West syndrome). Med Hypotheses, 2006, 67, 721-724.
57. Jennekens FG, Kater L: The central nervous system in systemic lupus erythematosus. Part 1. Clinical syndromes: a literature investigation. Rheumatology, 2002, 41, 605-618.
58. Jennekens FG, Kater L: The central nervous system in systemic lupus erythematosus. Part 2. Clinical syndromes: a literature investigation. Rheumatology, 2002, 41, 619-630.
59. Kalashnikova LA, Dobrynina LA, Aleksandrova EN, Novikov AA: Neurological appearances of primary antiphospholipid syndrome. Zh Neurol Psikhiatr Im S S Korsakova, 2005, Suppl, 13, 19-24.
60. Kanemoto K, Kawasaki J, Miyamoto T, Obayashi H, Nishimura M: Interleukin (IL)-1β, IL-1α, and IL-1 receptor antagonist gene polymorphisms in patients with temporal lobe epilepsy. Ann Neurol, 2000, 47, 571-574.
61. Kanemoto K, Kawasaki J, Yuasa S, Kumaki T, Tomohiro O, Kaji R, Nishimura M: Increased frequency of interleukin-1β-511T allele in patients with temporal lobe epilepsy, hippocampal sclerosis, and prolonged febrile convulsion. Epilepsia, 2003, 44, 796-799.
62. Kanter IC, Huttner HB, Staykov D, Biermann T, Struffert T, Kerling F, Hilz MJ et al.: Cyclophosphamide for anti-GAD antibody-positive refractory status epilepticus. Epilepsia, 2008, 49, 914-920.
63. Karpiak SE, Graf L, Rapport MM: Antiserum to brain gangliosides produces recurrent epileptiform activity. Science, 1976, 194, 735-737.
64. Karpiak SE, Huang YL, Rapport MM: Immunological model of epilepsy. Epileptiform activity induced by fragments of antibody to GM1 ganglioside. J Neuroimmunol, 1982, 3, 15-21.
65. Karpiak SE, Mahadik SP, Graf L, Rapport MM: An immunological model of epilepsy: seizures induced by antibodies to GM1 ganglioside. Epilepsia, 1981, 22, 189-196.
66. Kash SF, Johnson RS, Tecott LH, Noebels JL, Mayfield RD, Hanahan D, Baekkeskov S: Epilepsy in mice deficient in the 65-kDa isoform of glutaric acid decarboxylase. Proc Natl Acad Sci USA, 1997, 94, 14060-14065.
67. Landau WM, Kleffner FR: Syndrome of acquired aphasia with convulsive disorder in children. Neurology, 1957, 8, 523-530.
68. Lehtimaki KA, Keranen T, Huhtala H, Hurme M, Ollikainen J, Honkaniemi J, Palmio J, Peltola J: Regulation of IL-6 system in cerebrospinal fluid and serum compartments by seizures: the effect of seizures type and duration. J Neuroimmunol, 2004, 152, 121-125.
69. Levite M, Fleidervish IA, Schwarz A, Pelled D, Futerman AH: Autoantibodies to the glutamate receptor kill neurons via activation of the receptor ion channel. J Autoimmun, 1999, 13, 61-72.
70. Li Q, Guo M, Xu X, Xiao X, Xu W, Sun X, Tao H, Li R: Rapid decrease of GAD67 content before the convulsions induced by hyperbaric oxygen exposure. Neurochem Res, 2008, 33, 185-193.
71. Lin SC, Shyur SD, Li-Hsin-Huang Wu JY, Ma YC: Focal seizures as an unusual presentation of neonatal lupus erythematosus. Asian Pac J Allergy Immunol, 2005, 23, 61-64.
72. Liou HH, Wang CR, Chen CJ, Chen RC, Chuang CY, Chiang IP, Tsai MC: Elevated levels of anticardiolipin antibodies and epilepsy in lupus patients. Lupus, 1996, 5, 307-312.
73. Liou HH, Wang CR, Chou HC, Arvanov VL, Chen RC, Chang YC, Chuang CY et al.: Anticardiolipin antisera from lupus patients with seizures reduce a GABAreceptor mediated chloride current in snail neurons. Life Sci, 1994, 54, 1119-1125.
74. Lloyd KG, Bossi L, Morselli PL, Munari C, Rougier M, Loiseau H: Alterations of GABA-mediated synaptic transmission in human epilepsy. Adv Neurol, 1986, 44, 1033-1044.
75. Majoie HJ, de Baets M, Renier W, Lang B, Vincent A: Antibodies to voltage-gated potassium and calcium channels in epilepsy. Epilepsy Res, 2006, 71, 135-141.
76. Malfatti CR, Perry ML, Schweigert ID, Muller AP, Paquetti L, Rigo FK, Fighera MR et al.: Convulsions induced by methylmalonic acid are associated with glutamic acid decarboxylase inhibition in rats: a role for GABA in the seizures presented by methylmalonic acidemic patients? Neurosci, 2007, 146, 1879-1887.
77. McKnight K, Jiang Y, Hart Y, Cavey A, Wroe S, Blank M, Shoenfeld Y et al.: Serum antibodies in epilepsy and seizure-associated disorders. Neurology, 2005, 65, 1730-1736.
78. Mecarelli O, de Feo MR, Accornero N, Paffetti A: Systemic lupus erythematosus and myoclonic epileptic manifestations. Ital J Neurol Sci, 1999, 20, 129-132.
79. Mikailovic LJT, Cupic D: Epileptiform activity evoked by intracerebral injection of anti-brain antibodies. Brain Res, 1971, 32, 97-124.
80. Mikati MA, Saab R: Successful use of intravenous immunoglobulin as initial monotherapy in Landau-Kleffner syndrome. Epilepsia, 2000, 41, 880-886.
81. Mok CC, Lau CS, Wong RW: Neuropsychiatric manifestations and their clinical associations in Southern Chinese patients with systemic lupus erythematosus. J Rheumatol, 2001, 28, 766-771.
82. Montegazza R, Bernasconi P, Baggi F, Spreafico R, Ragona F, Antozzi C, Bernardi G, Granata T: Antibodies against GluR3 peptides are not specific for Rasmussen's encephalitis but are also present in epilepsy patients with severe, early onset disease and intractable seizures. J Neuroimmunol, 2002, 131, 179-185.
83. Mumenthaler M, Mattle H, Taub E: Neurology. Thieme, New York, 2004, 493-532.
84. Nemni R, Braghi S, Natali-Sora MG, Lampasowa V, Bonifacio E, Comi G, Canal N: Autoantibodies to glutamic acid decarboxylase in palatal myoclonus and epilepsy. Ann Neurol, 1994, 36, 665-667.
85. Nevsimalova S, Tauberova A, Doutlík S, Kucera V, Dlouhá O: A role of autoimmunity in the etiopathogenesis of Landau-Kleffner syndrome? Brain Dev, 1992, 14, 342-345.
86. Ozkara C, Altintas A, Yilmaz E, Eskazan E, Erkol G, Ozyurt E, Erdogan E, Kuday C: An association between mesial temporal lobe epilepsy with hippocampal sclerosis and human leukocyte antigens. Epilepsia, 2002, 43, 236-239.
87. Peltola J, Kulmala P, Isojärvi J, Saiz A, Latvala K, Palmio J, Savola K et al.: Autoantibodies to glutamic acid decarboxylase in patients with therapy-resistant epilepsy. Neurol, 2000, 55, 46-50.
88. Peltola J, Laaksonen J, Haapala AM, Hurme M, Rainesalo S, Keranen T: Indicators of inflammation after recent tonic-clonic epileptic seizures correlate with plasma interleukin-6 levels. Seizure, 2002, 11, 44-46.
89. Peltola J, Palmio J, Korhonen L, Suhonen J, Miettinen A, Hurme M, Lindholm D, Keranen T: Interleukin-6 and interleukin-1 receptor antagonist in cerebrospinal fluid from patients with recent tonic-clonic seizures. Epilepsy Res, 2000, 41, 205-211.
90. Ransom CB, Blumenfeld H: Acquired epilepsy: cellular and molecular mechanisms. In: Molecular Neurology. Ed. Waxman SG, Elsevier Academic Press, Burlington, 2007, 347-370.
91. Ravizza T, Vezzani A: Status epilepticus induces timedependent neuronal and astrocytic expression of interleukin-1 receptor type I in the rat limbic system. Neuroscience, 2006, 137, 301-308.
92. Rogers SW, Andrews PI, Gahring LC, Whisenand T, Cauley K, Crain B, Hughes TE et al.: Autoantibodies to glutamate receptor GluR3 in Rasmussens's encephalitis. Science, 1994, 26, 648-651.
93. Sayyah M, Beheshti S, Shokrgozar MA, Eslami-far A, Deljoo Z, Khabiri AR, Haeri Rohani A: Antiepileptogenic and anticonvulsant activity of interleukin-1β in amygdala-kindled rats. Exp Neurol, 2005, 191, 145-153.
94. Shandra AA, Godlevsky LS, Vastyanov RS, Oleinik AA, Konovalenko VL, Rapoport EN, Korobka NN: The role of TNF-α in amygdala kindled rats. Neurosci Res, 2002, 42, 147-153.
95. Shaw PJ, Walls TJ, Newman PK, Cleland PG, Cartlidge NE: Hashimoto's encephalopathy: a steroid-responsive disorder associated with high anti-thyroid antibody titers - report of 5 cases. Neurology, 1991, 41, 228-233.
96. Sheng JG, Boop FA, Griffin WS: Increased neuronal beta-amyloid precurosor protein expression in human temporal lobe epilepsy: association with interleukin-1 alpha immunoreactivity. J Neurochem, 1994, 11, 1872-1879.
97. Shoenfeld Y, Lev S, Blatt I, Blank M, Font J, von Landenberg P, Lev N et al.: Features associated with epilepsy in the antiphospholipid syndrome. J Rheumatol, 2004, 31, 1344-1348.
98. Shrivastava A, Dwivedi A, Aggarwal A, Misra R: Anticardiolipin and anti-beta2 glycoprotein I antibodies in Indian patients with systemic lupus erythematosus: association with the presence of seizures. Lupus, 2001, 10, 45-50.
99. Sinclair DB: Prednisone therapy in pediatric epilepsy. Pediatr Neurol, 2003, 28, 194-198.
100. Solimena M, Folli F, Aparisi R, Pozza G, De Camilli P: Autoantibodies to GABA-ergic neurons and pancreatic beta cells in stiff-man syndrome. N Engl J Med, 1990, 322, 1555-1560.
101. Steenland HW, Kin SS, Zhuo M: GluR3 subunit regulates sleep, breathing and seizure generation. Eur J Neurosci, 2008, 27, 1166-1173.
102. Twyman RE, Gahring LC, Spiess J, Rogers SW: Glutamate receptor antibodies activate a subset of receptors and reveal an agonist binding site. Neuron, 1995, 14, 755-762.
103. Van Engelen BG, Renier WO, Weemaes CM, Strengers PF, Bernsen PJ, Notermans SL: High-dose intravenous immunoglobulin treatment in cryptogenic West and Lennox-Gastaut syndrome; an add-on study. Eur J Pediatr, 1994, 153, 762-769.
104. Van Engelen BG, Weemaes CM, Renier WO, Bakkeren JA, Borm GF, Strengers PF: A disbalanced immune system in cryptogenic Lennox-Gastaut syndrome. Scand J Immunol, 2, 1995, 209-213.
105. Verrot D, San-Marco M, Dravet C, Genton P, Disdier P, Bolla G, Harle JR et al.: Prevalence and signification of antinuclear and anticardiolipin antibodies in patients with epilepsy. Am J Med, 1997, 103, 33-37.
106. Vezzani A, Conti M, De Luigi A, Ravizza T, Moneta D, Marchesi F, De Simoni MG: Interleukin-1β immunoreactivity and microglia are enhanced in the rat hippocampus by focal kainate application: functional evidence for enhancement of electrographic seizures. J Neurosci, 1999, 19, 5054-5065.
107. Vezzani A, Granata T: Brain inflammation in epilepsy: experimental and clinical evidence. Epilepsia, 2005, 46, Suppl 5, 1724-1743.
108. Vezzani A, Moneta D, Richichi C, Aliprandi M, Burrows SJ, Ravizza T: Functional role of inflammatory cytokines and anti-inflammatory molecules in seizures and epileptogenesis. Epilepsia, 2002, 43, 30-35.
109. Villani F, Avanzini G: The use of immunoglobulins in the treatment of human epilepsy. Neurol Sci, 2002, 23, Suppl 1, S33-37.
110. Vincent A, Lang B, Kleopa KA: Autoimmune channelopathies and related neurological disorders. Neuron, 2006, 52, 123-138.
111. Vulliemoz S, Vanini G, Truffert A, Chizzolini C, Seeck M: Epilepsy and cerebellar ataxia associated with antiglutamic acid decarboxylase antibodies. J Neurol Neurosurg Psychiatry, 2007, 78, 187-189.
112. Watson R, Jiang Y, Bermudez I, Houlihan L, Clover L, McKnight K, Cross JH et al.: Absence of antibodies to glutamate receptor type 3 (GluR3) in Rasmussen encephalitis. Neurology, 2004, 63, 43-50.
113. Whitney KD, Andrews PI, McNamara JO: Immunoglobulin G and complement immunoreactivity in the cerebral cortex of patients with Rasmussen's encephalitis. Neurology, 1999, 11, 699-708.
114. Wu G, Lu ZH, Wang J, Wang Y, Xie X, Meyenhofer MF, Ledeen RW: Enhanced succeptibility to kinate-induced seizures, neuronal apoptosis and death in mice lacking gangliotetraose gangliosides: protection with LIGA 20 a membrane-permeant analog of GM1. J Neurosci, 2005, 25, 11014-11022.
115. Yamatogi Y, Ohtsuka Y, Ishida T, Ichiba N, Ishida S, Miyake S, Oka E, Ohtahara S: Treatment of the Lennox syndrome with ACTH: a clinical and electroencephalographic study. Brain Dev, 1979, 1, 267-276.
116. Yang R, Puranam RS: Autoimmunity to munc-18 in Rasmussen's encephalitis. Neuron, 2000, 28, 309-310.